Retraction: Salari et al. Diabetol Metab Syndr _#####################_
The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding the reliability of the reported data, which the authors addressed by a Correction [1]. However, further issues were subsequently identified with the authors potentially reporting mean differences as standardized mean differences. Post-publication peer review has concluded that the authors’ methodology contains technical and statistical errors, which undermine the conclusions of the article.
Authors Kamran Mansouri and Masoud Mohammadi disagree with this retraction. The other authors have not responded to correspondence regarding this retraction.
Reference
Salari, N., Jafari, S., Darvishi, N. et al. Correction to: The best drug supplement for obesity treatment: a systematic review and network meta-analysis. Diabetol Metab Syndr 14, 68 (2022). https://doi.org/10.1186/s13098-022-00838-5
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13098-021-00733-5
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Salari, N., Jafari, S., Darvishi, N. et al. Retraction Note: The best drug supplement for obesitytreatment: a systematic review and network meta-analysis. Diabetol Metab Syndr 15, 74 (2023). https://doi.org/10.1186/s13098-023-01048-3
Published:
DOI: https://doi.org/10.1186/s13098-023-01048-3